Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis

Human Reproduction Update

Volumn 13, Issue 4, 2007, Pages 343-355

  Venetis, C A ^a   Kolibianakis, E M ^a   Papanikolaou, E ^a   Bontis, J ^a   Devroey, P ^b   Tarlatzis, B C ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

HCG; Ovarian stimulation; Pregnancy; Progesterone

Indexed keywords

BUSERELIN; CETRORELIX; CHORIONIC GONADOTROPIN; GONADORELIN DERIVATIVE; GONADOTROPIN; LEUPRORELIN; NAFARELIN; PROGESTERONE; TRIPTORELIN;

CLINICAL TRIAL; CORRELATION ANALYSIS; EMBASE; FERTILIZATION IN VITRO; HUMAN; IMMUNOASSAY; MEDLINE; META ANALYSIS; OOCYTE MATURATION; OUTCOME ASSESSMENT; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; PROBABILITY; PROGESTERONE BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

CHORIONIC GONADOTROPIN; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PROBABILITY; PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 34447300178     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmm007     Document Type: Review

References (57)

1. Abuzeid MI, Sasy MA. Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertil Steril 1996;65:981-5.
2. Antoine JM, Firmin C, Salat-Baroux J et al. Prognostic value of preovulatory elevations of plasma progesterone during in vitro fertilization using LHRH agonists in a long protocol. J Gynecol Obstet Biol Reprod (Paris) 1992;21:629-34.
3. Bodis J, Torok A, Garai J et al. Preovulatory rise in progesterone (multiple letters) [2]. Hum Reprod 1998;13:2657-8.
4. Bosch E, Valencia I, Escudero E et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 2003;80:1444-9.
5. Bustillo M, Stern JJ, Coulam CB. Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer. Hum Reprod 1995;10 2862-2867.
6. Check JH, Lurie D, Askari HA et al. The range of subtle rise in serum progesterone levels following controlled ovarian hyperstimulation associated with lower in vitro fertilization pregnancy rates is determined by the source of manufacturer. Eur J Obstet Gynecol Reprod Biol 1993a;52:205-209.
7. Check JH, Lurie D, Hoover L et al. Association of higher pregnancy rates with low serum progesterone levels (by radioimmunoassay) at the time of human chorionic gonadotropin not corroborated when using a nonisotopic immunoassay. J Assist Reprod Genet 1993b;10 384-7.
8. Check JH. Predictive value of serum progesterone levels for pregnancy outcome? Fertil Steril 1994;62:1090-1.
9. Check JH, Hourani C, Choe JK et al. Pregnancy rates in donors versus recipients according to the serum progesterone level at the time of human chorionic gonadotropin in a shared oocyte program. Fertil Steril 1994;61:262-4.
10. Cochran WG. Some consequences when the assumptions in the analysis of variance are not satisfied. Biometrics 1974;3:22-28.
11. Dickersin K, Berlin JA. Meta-analysis: State-of-the-science. Epidemiol Rev 1992;14:154-76.
12. Dirnfeld M, Goldman S, Gonen Y et al. A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization-embryo transfer (IVF-ET) patients. J Assist Reprod Genet 1993;10:126-9.
13. Doldi N, Marsiglio E, Destefani A et al. Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod 1999;14:601-5.
14. Dumesic DA. Periovulatory serum progesterone levels as a predictor of pregnancy outcome during ovarian hyperstimulation for assisted reproductive technology. Fertil Steril 1994;62:911-2.
15. Edelstein MC, Seltman HJ, Cox BJ et al. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 1990;54:853-7.
16. Emperaire JC, Ruffie A, Ruedas E et al. The value of plasma progesterone for monitoring the IVF cycle. J Gynecol Obst Bio R 1989;18,103-8.
17. Fanchin R. Understanding the genesis and consequences of premature progesterone elevation. Assist Reprod 1999;9:121-8.
18. Fanchin R, de Ziegler D, Taieb J et al. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993;59:1090-4.
19. Fanchin R, Righini C, Olivennes F et al. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril 1996;65:1178-83.
20. Fanchin R, Hourvitz A, Olivennes F et al. Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture. Fertil Steril 1997a;68:648-52.
21. Fanchin R, Righini C, Olivennes F et al. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil Steril 1997b;68:799-805.
22. Farina A, Ogasawara M, Kajiura S et al. Predictive value of serum progesterone levels [3] (multiple letters). Fertil Steril 1998; 69:977-8.
23. Givens CR, Schriock ED, Dandekar PV et al. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994;62:1011-7.
24. Harada T, Yoshida S, Katagiri C et al. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod 1995;10:1060-4.
25. Harada T, Toda T, Katagiri C et al. Altering the timing of human chorionic gonadotropin injection according to serum progesterone (P) concentrations improves embryo quality in cycles with subtle P rise. Fertil Steril 1996;65:594-7.
26. Hassiakos D, Toner JP, Muasher SJ et al. Implantation and pregnancy rates in relation to oestradiol and progesterone profiles in cycles with and without the use of gonadotrophin-releasing hormone agonist suppression. Hum Reprod 1990;5:1004-8.
27. Hofmann GE, Bentzien F, Bergh PA et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 1993;60:675-9.
28. Hofmann GE, Khoury J, Johnson CA et al. (1996) Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil Steril 1996;66:980-6.
29. Huang JC, Jackson KV, Hornstein MD et al. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer. J Assist Reprod Genet 1996;13 617-24.
30. Jacobson A, Weckstein LN, Galen DI. Predictive value of progesterone and estradiol levels for pregnancy. Fertil Steril 1994;61:192-3.
31. Kagawa T, Yamano S, Nishida S et al. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET). J Assist Reprod Genet 1992;9:106-12.
32. Kolibianakis EM, Collins J, Tarlatzis BC. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006;12:651-71.
33. Kruskal W. Miracles and statistics: The casual assumption of independence. J Am Stat Assoc 1988;83:929-937.
34. Legro RS, Ary BA, Paulson RJ et al. Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. Hum Reprod 1993;8:1506-11.
35. Levine DW, Rockhill B. I Remember You: Independence and the Binomial Model. Teach Stat 2006;28:44-8.
36. Levy MJ, Smotrich DB, Widra EA et al. The predictive value of serum progesterone and 17-OH progesterone levels on in vitro fertilization outcome. J Assist Reprod Genet 1995;12:161-6.
37. Lindheim SR, Cohen MA, Chang PL et al. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet 1999;16:242-6.
38. Martinez F, Coroleu B, Clua E et al. Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod Biomed Online 2004;8 183-90.
39. McFaul PB, Traub AI, Thompson W. Premature luteinization and ovulation induction using human menopausal gonadotrophin or pure follicle stimulating hormone in patients with polycystic ovary syndrome. Acta Eur Fertil 1989;20:157-61.
40. Miller KF, Behnke EJ, Arciaga RL et al. The significance of elevated progesterone at the time of administration of human chorionic gonadotropin may be related to luteal support. J Assist Reprod Genet 1996;13:698-701.
41. Mio Y, Sekijima A, Iwabe T et al. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil Steril 1992;58:159-66.
42. Moffitt DV, Queenan JT Jr, Shaw R. Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort. Fertil Steril 1997;67:296-301.
43. Porter RN, Smith W, Craft IL et al. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 1984;2:1284-5.
44. Prien SD, Canez MS, Messer RH. Increases in progesterone after human chorionic gonadotropin administration may predict cycle outcome in patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 1994;62:1066-8.
45. Randall GW, Gantt PA, Gantt D et al. (1996) Elevated serum progesterone values at the time of ovulation induction in luteal leuprolide acetate-down-regulated GIFT cycles are associated with decreased clinical pregnancy rates. J Assist Reprod Genet 1996; 13:459-63.
46. Schoolcraft W, Sinton E, Schlenker T et al. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991;55:563-6.
47. Sekijima A. Relation between the outcome of IVF-ET and subtle rise in serum progesterone during the follicular phase stimulated with a combination of gonadotropin-releasing hormone analog and gonadotropin. Nippon Sanka Fujinka Gakkai Zasshi 1993;45:249-55.
48. Shulman A, Ghetler Y, Beyth Y et al. The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a "long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins. J Assist Reprod Genet 1996;13:207-11.
49. Silverberg KM, Burns WN, Olive DL et al. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1991;73:797-803.
50. Silverberg KM, Martin M, Olive DL et al. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization cycles do not adversely affect embryo quality. Fertil Steril 1994;61:508-13.
51. Smitz J, Ron-El R, Tarlatzis BC. The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: Experience from three centres. Hum Reprod 1992;7:49-66.
52. Ubaldi F, Smitz J, Wisanto, A et al. Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. Hum Reprod 1995;10:3091-6.
53. Ubaldi F, Camus M, Smitz J et al. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 1996a;66:275-80.
54. Ubaldi F, Albano C, Peukert M et al. Subtle progesterone, rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum Reprod 1996b;11:1405-7.
55. Urman B, Alatas C, Aksoy S et al. Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer. Fertil Steril 1999;72:975-9.
56. Yovel I, Yaron Y, Amit A et al. High progesterone levels adversely affect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs. Fertil Steril 1995;64:128-31.
57. Zimmerman DW. Effect of nonindependence of sample observations on some parametric and nonparametric statistical tests. Commun Stat B-Simul 1993;22:779-89.